electroCore (ECOR) Free Cash Flow Growth (5y) (2022 - 2026)
electroCore (ECOR) Free Cash Flow Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | electroCore | 55,508.60 | -8.77 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.25% |
| Dec 31, 2025 | -46.52% |
| Sep 30, 2025 | 37.55% |
| Jun 30, 2025 | 31.58% |
| Mar 31, 2025 | 12.17% |
| Dec 31, 2024 | 16.34% |
| Sep 30, 2024 | 16.76% |
| Jun 30, 2024 | 21.10% |
| Mar 31, 2024 | 31.07% |
| Dec 31, 2023 | 17.71% |
| Sep 30, 2023 | 16.64% |
| Jun 30, 2023 | 27.15% |
| Mar 31, 2023 | 9.81% |
| Dec 31, 2022 | 13.10% |
| Sep 30, 2022 | 6.94% |